Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 16.33 is 13% above its 2-year average of 14.50, near the high end of its 2-year range (7.37–19.49).
As of the fiscal period ended Tuesday, June 30, 2026. 24.50% above its 12-month average of 13.11.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 16.33.
CURRENT RATIO
16.33
CURRENT RATIO AVG TTM
13.11
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+24.50%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 624 covered companies
CURRENT VS SECTOR MEDIAN
+380.90%
vs the sector median at left
Market Cap
$978.16M
Current Ratio
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$999.23M
Current Ratio
16.35
TTM Avg
49.13
3Y Avg
36.30
5Y Avg
29.95
Market Cap
$1.02B
Current Ratio
8.42
TTM Avg
11.89
3Y Avg
15.48
5Y Avg
17.00
Market Cap
$1.02B
Current Ratio
3.40
TTM Avg
1.85
3Y Avg
2.70
5Y Avg
2.88
Market Cap
$1.02B
Current Ratio
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | $986.27M | 16.33 | 13.11 | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | 3.76 | 1.39 | 1.76 | 2.46 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $978.16M | 15.08 | 22.50 | 27.08 | 27.08 |
| Janux Therapeutics, Inc. (JANX)vs › | $999.23M | 16.35 | 49.13 | 36.30 | 29.95 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.01B | 7.54 | 10.49 | 6.85 | 5.34 |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.02B | 8.42 | 11.89 | 15.48 | 17.00 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | 3.40 | 1.85 | 2.70 | 2.88 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Kura Oncology, Inc. (KURA)vs › | $929.47M | 4.73 | 7.76 | 11.59 | 15.68 |
Current Ratio
16.33
Quick Ratio
16.33
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 16.33 |
| 2026-03-31 | 19.49 |
| 2025-12-31 | 7.37 |
| 2025-09-30 | 9.27 |
| 2024-12-31 | 15.98 |
| 2024-09-30 | 18.55 |
